JP2564412B2 - 薬剤耐性癌に対するキメラ抗体およびその製造 - Google Patents

薬剤耐性癌に対するキメラ抗体およびその製造

Info

Publication number
JP2564412B2
JP2564412B2 JP2051563A JP5156390A JP2564412B2 JP 2564412 B2 JP2564412 B2 JP 2564412B2 JP 2051563 A JP2051563 A JP 2051563A JP 5156390 A JP5156390 A JP 5156390A JP 2564412 B2 JP2564412 B2 JP 2564412B2
Authority
JP
Japan
Prior art keywords
chain
chimeric
human
gene
mouse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2051563A
Other languages
English (en)
Japanese (ja)
Other versions
JPH03254691A (ja
Inventor
鶴尾　　隆
洋文 浜田
良和 黒沢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUJITA GAKUEN KK
GAN KENKYUKAI
Original Assignee
FUJITA GAKUEN KK
GAN KENKYUKAI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUJITA GAKUEN KK, GAN KENKYUKAI filed Critical FUJITA GAKUEN KK
Priority to JP2051563A priority Critical patent/JP2564412B2/ja
Priority to CA002025695A priority patent/CA2025695A1/fr
Publication of JPH03254691A publication Critical patent/JPH03254691A/ja
Application granted granted Critical
Publication of JP2564412B2 publication Critical patent/JP2564412B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2051563A 1990-03-02 1990-03-02 薬剤耐性癌に対するキメラ抗体およびその製造 Expired - Fee Related JP2564412B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2051563A JP2564412B2 (ja) 1990-03-02 1990-03-02 薬剤耐性癌に対するキメラ抗体およびその製造
CA002025695A CA2025695A1 (fr) 1990-03-02 1990-09-19 Anticorps chimeriques contre les cancers resistants aux drogues et procede de production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2051563A JP2564412B2 (ja) 1990-03-02 1990-03-02 薬剤耐性癌に対するキメラ抗体およびその製造

Publications (2)

Publication Number Publication Date
JPH03254691A JPH03254691A (ja) 1991-11-13
JP2564412B2 true JP2564412B2 (ja) 1996-12-18

Family

ID=12890444

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2051563A Expired - Fee Related JP2564412B2 (ja) 1990-03-02 1990-03-02 薬剤耐性癌に対するキメラ抗体およびその製造

Country Status (2)

Country Link
JP (1) JP2564412B2 (fr)
CA (1) CA2025695A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147500A (ja) * 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
JPS6261596A (ja) * 1985-09-11 1987-03-18 Japan Found Cancer Res 薬剤耐性癌に関するモノクロ−ナル抗体およびその製造

Also Published As

Publication number Publication date
JPH03254691A (ja) 1991-11-13
CA2025695A1 (fr) 1991-09-03

Similar Documents

Publication Publication Date Title
CA2035899C (fr) Anticorps anti-antigene carcino-embryonnaire chimerique
Greenwood et al. Structural motifs involved in human IgG antibody effector functions
Fell et al. Homologous recombination in hybridoma cells: heavy chain chimeric antibody produced by gene targeting.
AU606320B2 (en) Modular assembly of antibody genes, antibodies prepared thereby and use
CA1341351C (fr) Production d'anticorps chimeres souris-homme, specifiques pour les antigenes tumoraux chez l'homme
JP2991720B2 (ja) 抗体遺伝子のモジュールの会合、それによって製造される抗体およびその用途
EP0266663B1 (fr) Anticorps chimérique spécifique pour antigène à tumeur humaine
AU634314B2 (en) Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen
EP0369566A2 (fr) Anticorps chimériques bifonctionnels
JPH02295487A (ja) キメラモノクローナル抗体の産生のための発現系
US5075431A (en) Chimeric anti-CEA antibody
KR970007782B1 (ko) 특이적 결합제
EP1358318B1 (fr) Lignee de cellules d'hybridomes g250 et son utilisation pour produire des anticorps monoclonaux
CA2070182C (fr) Immunoglobuline chimerique pour recepteurs cda
AU2002238537A1 (en) Hybridoma cell line G250 and its use for producing monoclonal antibodies
CA2019323A1 (fr) Anticorps km10 chimeriques humain - murin specifiques contre un antigene de cellules tumorales humaines
JP2564412B2 (ja) 薬剤耐性癌に対するキメラ抗体およびその製造
Ariyoshi et al. Mouse‐human chimeric antibody MH171 against the multidrug transporter P‐glycoprotein
US7037496B2 (en) Chimeric immunoglobulin for CD4 receptors
KR20230072536A (ko) 인간화된 cd22에 특이적인 항체 및 이를 이용한 키메라 항원 수용체
EP1733736B1 (fr) Procédé de production des anticorps recombinants contre des tumeurs

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees